JAK-IN-35

• UNSPSC Description:

  JAK-IN-35 (compound TG46) is a JAK2 inhibitor that canb be used in cancer research[1].

• Target Antigen:

  JAK

• Type:

  Reference compound

• Related Pathways:

  Epigenetics;JAK/STAT Signaling;Protein Tyrosine Kinase/RTK;Stem Cell/Wnt

• Applications:

  Cancer-Kinase/protease

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/jak-in-35.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=S(C1=CC=CC(NC2=NC(NC3=CC=C(CN4CCOCC4)C=C3)=NC=C2C)=C1)(NC(C)(C)C)=O

• Molecular Weight:

  510.65

• References & Citations:

  [1]Wenge Zhu, et al. Combination therapy for treating cancer. Patent WO2018187485A1.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  936091-15-5